1-4 of 4
Osman Cen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Pro-Survival Pathways in DLBCL Cells By Functional Lipoprotein-like Nanoparticles

Jonathan Rink, PhD, Shuo Yang, PhD, Osman Cen, PhD, Reem Karmali, MD, Colby Shad Thaxton, MD PhD, Leo I. Gordon, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1668.
https://doi.org/10.1182/blood-2018-99-119122
Published: 2018
Journal Articles

Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO)

Jonathan Rink, PhD, Osman Cen, PhD, Kaylin Marie McMahon, PhD, Sol Misener, BS, Shuo Yang, PhD, Colby Shad Thaxton, MD PhD, Leo I. Gordon, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 576.
https://doi.org/10.1182/blood.V130.Suppl_1.576.576
Published: 2017
Journal Articles

High Density Lipoprotein-like Nanoparticles Synergize with Akt and Btk Inhibitors to Induce Cell Death in Diffuse Large B Cell Lymphomas

Jonathan Scott Rink, PhD, Sol Misener, Osman Cen, PhD, Shuo Yang, Leo I. Gordon, MD, Colby Shad Thaxton, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3022.
https://doi.org/10.1182/blood.V128.22.3022.3022
Published: 2016
Journal Articles

The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

Osman Cen, PhD, Karuppiah Kannan, PhD, Jessica J. Huck, M.A., Jie Yu, M.S., Mengkun Zhang, MD, Leo I Gordon, MD, Richard Longnecker, PhD
Journal: Blood
Blood (2016) 128 (22): 4179.
https://doi.org/10.1182/blood.V128.22.4179.4179
Published: 2016